Addendum to ICH S6 preclinical safety evaluation of biotechnology-derived pharmaceuticals.
(eBook)
Contributors
Published
[Rockville, Md.? : U.S. Dept. of Health and Human Services, Food and Drug Administration, 2009].
Status
Description
Loading Description...
Also in this Series
Checking series information...
More Details
Format
eBook
Language
English
Notes
General Note
"ICH harmonised tripartite guideline."
General Note
"S6(R1)."
General Note
"Current step 2 version, dated October 29, 2009."
General Note
GPO Cataloging Record Distribution Program (CRDP).
Bibliography
Includes bibliographical references (p. 14).
Citations
APA Citation, 7th Edition (style guide)
(2009). Addendum to ICH S6: preclinical safety evaluation of biotechnology-derived pharmaceuticals . U.S. Dept. of Health and Human Services, Food and Drug Administration.
Chicago / Turabian - Author Date Citation, 17th Edition (style guide)2009. Addendum to ICH S6: Preclinical Safety Evaluation of Biotechnology-derived Pharmaceuticals. U.S. Dept. of Health and Human Services, Food and Drug Administration.
Chicago / Turabian - Humanities (Notes and Bibliography) Citation, 17th Edition (style guide)Addendum to ICH S6: Preclinical Safety Evaluation of Biotechnology-derived Pharmaceuticals U.S. Dept. of Health and Human Services, Food and Drug Administration, 2009.
MLA Citation, 9th Edition (style guide)Addendum to ICH S6: Preclinical Safety Evaluation of Biotechnology-derived Pharmaceuticals U.S. Dept. of Health and Human Services, Food and Drug Administration, 2009.
Note! Citations contain only title, author, edition, publisher, and year published. Citations should be used as a guideline and should be double checked for accuracy. Citation formats are based on standards as of August 2021.
Staff View
Grouped Work ID
961bdb98-8ebf-c0cc-55a3-0707bccab479-eng
Grouping Information
| Grouped Work ID | 961bdb98-8ebf-c0cc-55a3-0707bccab479-eng |
|---|---|
| Full title | addendum to ich s6 preclinical safety evaluation of biotechnology derived pharmaceuticals |
| Author | united states |
| Grouping Category | book |
| Last Update | 2023-05-05 15:45:20PM |
| Last Indexed | 2024-06-13 00:13:23AM |
Book Cover Information
| Image Source | default |
|---|---|
| First Loaded | Sep 18, 2022 |
| Last Used | Jul 5, 2023 |
Marc Record
| First Detected | Dec 23, 2009 12:00:00 AM |
|---|---|
| Last File Modification Time | May 05, 2023 03:50:47 PM |
MARC Record
| LEADER | 01298cam a2200337Ia 4500 | ||
|---|---|---|---|
| 001 | ocn493493259 | ||
| 003 | OCoLC | ||
| 005 | 20091223161236.0 | ||
| 006 | m d f | ||
| 007 | cr a|||||||||| | ||
| 008 | 091223s2009 mdu ob f000 0 eng d | ||
| 040 | |a GPO|c GPO|d MvI | ||
| 043 | |a n-us--- | ||
| 074 | |a 0475 (online) | ||
| 086 | 0 | |a HE 20.4002:B 52 | |
| 099 | |a HE 20.4002:B 52 | ||
| 245 | 0 | 0 | |a Addendum to ICH S6|h [electronic resource] :|b preclinical safety evaluation of biotechnology-derived pharmaceuticals. |
| 246 | 3 | 0 | |a Preclinical safety evaluation of biotechnology-derived pharmaceuticals |
| 260 | |a [Rockville, Md.? :|b U.S. Dept. of Health and Human Services, Food and Drug Administration,|c 2009] | ||
| 300 | |a 1 online resource (iv, 14 p.) | ||
| 500 | |a "ICH harmonised tripartite guideline." | ||
| 500 | |a "S6(R1)." | ||
| 500 | |a "Current step 2 version, dated October 29, 2009." | ||
| 500 | |a GPO Cataloging Record Distribution Program (CRDP). | ||
| 504 | |a Includes bibliographical references (p. 14). | ||
| 650 | 0 | |a Pharmaceutical biotechnology. | |
| 650 | 0 | |a Drugs|x Testing. | |
| 710 | 1 | |a United States.|b Food and Drug Administration. | |
| 711 | 2 | |a International Conference on Harmonisation. | |
| 856 | 4 | 0 | |u https://purl.fdlp.gov/GPO/LPS118023 |
| 949 | |a HE 20.4002:B 52|t x | ||